Director, Global Program Lead, External Innovation & Due Diligence

About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Please note that this position can be based in San Diego, CA, San Francisco, CA OR Princeton, NJ.    Acadia's hybrid model requires this role to work in our office three days per week on average. Position Summary:   The Director, External Innovation will serve as the R&D project/program lead for external opportunity due diligence, with a particular focus on clinical-stage assets and drug development programs. The role will lead cross-functional clinical, scientific, and strategic evaluation of opportunities aligned with Acadia’s corporate strategy and R&D portfolio across neuroscience, psychiatry, neuro-rare, and rare disease. The Director will support the development of preliminary integrated development scenarios, resource assumptions, and value drivers to inform opportunity evaluation, investment decisions, and governance discussions. As a strategic integrator across Business Development, Clinical and Nonclinical Development, Regulatory, CMC, Commercial, Finance, Legal, and other functions, the Director will synthesize complex scientific, clinical, competitive, and financial information into clear recommendations and executive-ready decision materials to support external asset evaluation, due diligence, and potential transaction execution. Primary Responsibilities: Serve as the R&D project lead for external opportunity due diligence, coordinating cross-functional input from Clinical and Nonclinical Development, Regulatory, CMC, Commercial, Finance, Legal, and other key stakeholders Lead or co-lead the development of diligence workplans, including key questions, timelines, risk assessments, decision frameworks, and preliminary integrated development scenarios, resource assumptions, and value drivers to inform investment decisions Build preliminary integrated development scenarios, resource assumptions, and value drivers to inform diligence and investment decisions Contribute to the development of integrated opportunity assessments that evaluate scientific rationale, clinical development strategy, unmet need, competitive differentiation, regulatory considerations, development risk, commercial potential, and strategic fit Apply clinical development and asset leadership expertise to identify key diligence questions, development risks, opportunities, and assumptions associated with external assets Translate complex scientific, clinical, competitive, and financial information into clear recommendations for senior leadership and governance decision-making Partner with Business Development to support in-licensing, acquisition, collaboration, and partnership evaluations, including preparation of internal business cases and transaction-related materials Provide strategic input into therapeutic area and portfolio prioritization based on external landscape trends, emerging science, competitive activity, and internal capabilities Build and maintain strong relationships with internal R&D, Commercial, Finance, Legal, and business stakeholders to ensure alignment throughout evaluation and diligence processes Represent Acadia in external scientific, biotech, academic, and industry interactions as appropriate to support opportunity evaluation and external innovation efforts Contribute to knowledge management, diligence best practices, evaluation templates, and consistent decision frameworks across external opportunities Perform other duties as assigned Education/Experience/Skills: Bachelor’s degree in a relevant scientific discipline required; advanced degree (PhD, PharmD, MD, or Master’s) preferred 10-12 years of industry experience in the pharma or biotech industry Experience in global R&D program management (clinical-stage assets), portfolio strategy or project leadership is required Experience with clinical-stage assets is required  Experience leading cross-functional asset evaluations, scientific due diligence, portfolio assessments, and/or drug development strategy initiatives Strong scientific expertise with the ability to evaluate complex clinical and preclinical data Experience in neuroscience and/or rare disease (neurologic/psychiatric and/or non‑neuro rare disease) preferred Understanding of drug development, commercialization considerations, and industry dynamics Ability to synthesize complex information into clear, actionable insights for senior stakeholders Strong cross‑functional collaboration and influencing skills in a matrixed environment Working knowledge of transaction processes, due diligence, and partnership structures Experience developing strategic recommendations and governance materials for senior leadership and investment decision-making Experience integrating scientific, clinical, regulatory, commercial, and financial considerations into asset evaluations and portfolio recommendations Experience supporting or leading external opportunity assessments, due diligence activities, and cross-functional evaluation teams Ability to manage multiple priorities and operate effectively in a fast‑paced environment Ability to travel domestically and internationally as required Physical Requirements: This role involves regular standing, walking, sitting, and the use of hands for handling or operating equipment. The employee may also need to reach, climb, bal